552 related articles for article (PubMed ID: 24006213)
41. Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications.
Galal AM; Slade D; Gul W; El-Alfy AT; Ferreira D; Elsohly MA
Recent Pat CNS Drug Discov; 2009 Jun; 4(2):112-36. PubMed ID: 19519560
[TBL] [Abstract][Full Text] [Related]
42. Involvement of the endocannabinoid system in osteoarthritis pain.
La Porta C; Bura SA; Negrete R; Maldonado R
Eur J Neurosci; 2014 Feb; 39(3):485-500. PubMed ID: 24494687
[TBL] [Abstract][Full Text] [Related]
43. Phytocannabinoids as novel therapeutic agents in CNS disorders.
Hill AJ; Williams CM; Whalley BJ; Stephens GJ
Pharmacol Ther; 2012 Jan; 133(1):79-97. PubMed ID: 21924288
[TBL] [Abstract][Full Text] [Related]
44. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?
Croxford JL; Yamamura T
J Neuroimmunol; 2005 Sep; 166(1-2):3-18. PubMed ID: 16023222
[TBL] [Abstract][Full Text] [Related]
45. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
46. [New targeted compounds-biosynthesis of phytocannabinoids].
Gao P; Chen Y; Ke C; Yang X; Huang J
Sheng Wu Gong Cheng Xue Bao; 2021 Jun; 37(6):1968-1985. PubMed ID: 34227288
[TBL] [Abstract][Full Text] [Related]
47. Limited range of indications for cannabis.
Wörz R
Dtsch Arztebl Int; 2013 Mar; 110(10):174. PubMed ID: 23533550
[No Abstract] [Full Text] [Related]
48. Role of cannabis in digestive disorders.
Goyal H; Singla U; Gupta U; May E
Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):135-143. PubMed ID: 27792038
[TBL] [Abstract][Full Text] [Related]
49. Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions.
Bell AD; MacCallum C; Margolese S; Walsh Z; Wright P; Daeninck PJ; Mandarino E; Lacasse G; Kaur Deol J; de Freitas L; St Pierre M; Belle-Isle L; Gagnon M; Bevan S; Sanchez T; Arlt S; Monahan-Ellison M; O'Hara J; Boivin M; Costiniuk C
Cannabis Cannabinoid Res; 2024 Apr; 9(2):669-687. PubMed ID: 36971587
[No Abstract] [Full Text] [Related]
50. Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.
Thapa D; Warne LN; Falasca M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834122
[TBL] [Abstract][Full Text] [Related]
51. Cannabinoids and multiple sclerosis.
Pertwee RG
Pharmacol Ther; 2002 Aug; 95(2):165-74. PubMed ID: 12182963
[TBL] [Abstract][Full Text] [Related]
52. Pharmacology of cannabinoids.
Grotenhermen F
Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
[TBL] [Abstract][Full Text] [Related]
53. Therapeutic potential of cannabinoid-based drugs.
Klein TW; Newton CA
Adv Exp Med Biol; 2007; 601():395-413. PubMed ID: 17713029
[TBL] [Abstract][Full Text] [Related]
54. [Therapeutic applications and biomedical effects of cannabinoids; pharmacological starting points].
Killestein J; Nelemans SA
Ned Tijdschr Geneeskd; 1997 Aug; 141(35):1689-93. PubMed ID: 9543785
[TBL] [Abstract][Full Text] [Related]
55. Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
Martínez V; Iriondo De-Hond A; Borrelli F; Capasso R; Del Castillo MD; Abalo R
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357565
[No Abstract] [Full Text] [Related]
56. Therapeutic potential of cannabis-related drugs.
Alexander SP
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():157-66. PubMed ID: 26216862
[TBL] [Abstract][Full Text] [Related]
57. Endogenous cannabinoid system as a modulator of food intake.
Cota D; Marsicano G; Lutz B; Vicennati V; Stalla GK; Pasquali R; Pagotto U
Int J Obes Relat Metab Disord; 2003 Mar; 27(3):289-301. PubMed ID: 12629555
[TBL] [Abstract][Full Text] [Related]
58. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.
O'Brien M; McDougall JJ
Curr Opin Pharmacol; 2018 Jun; 40():104-109. PubMed ID: 29635215
[TBL] [Abstract][Full Text] [Related]
59. Towards cannabis and cannabinoid treatment of multiple sclerosis.
Croxford JL; Miller SD
Drugs Today (Barc); 2004 Aug; 40(8):663-76. PubMed ID: 15510238
[TBL] [Abstract][Full Text] [Related]
60. A Proteomic View of Cellular and Molecular Effects of Cannabis.
Abyadeh M; Gupta V; Paulo JA; Gupta V; Chitranshi N; Godinez A; Saks D; Hasan M; Amirkhani A; McKay M; Salekdeh GH; Haynes PA; Graham SL; Mirzaei M
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
